Preskoči na vsebino

Posodobitev študije faze II GENERATION HD2

Roche has announced the continuation of the GENERATION HD2 Phase II clinical trial evaluating tominersen in individuals with early signs of Huntington’s disease. Following an interim analysis by an independent committee, no […]

Konferenca EHA 2025

Z veseljem sporočamo, da bo Evropsko združenje Huntington od 25. do 28. septembra 2025 v Bukarešti (Romunija) organiziralo svojo 5. polletno konferenco. "Skupaj oblikujemo našo prihodnost, mi smo sprememba!" izraža duh konference, ki je bila organizirana v [...]

Pogled nazaj na kongres HDYO 2025

The HDYO Congress 2025 brought together young people, families, researchers, and professionals from around the world for an unforgettable event dedicated to the Huntington’s Disease community. Over three inspiring days, […]

sl_SISlovenian